Probiotics offer potential ‘safe, low cost, non-antibiotic’ strategy for infections
Clostridium difficile infections have been noted by EU and US health authorities as an ‘emerging’ healthcare threat – costing the US $1bn annually. Now, researchers preparing a pilot study are looking at whether probiotics could be a solution.